Come up with a name for your new list and we'll add to it:
Surface Pharmaceuticals raised a round of funding on May 15, 2018. Investors include
Flying L Partners.
Surface Pharmaceuticals is a drug development company working on treatments for dry eye and blepharitis. Surface's pipeline includes eye drops SURF-100 and SURF-200, which combine the generic medicati…